Filing Details

Accession Number:
0000899243-21-028830
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-19 16:05:38
Reporting Period:
2021-07-16
Accepted Time:
2021-07-19 16:05:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB Pharmaceutical Preparations (2834) 831114349
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1792064 Ram Waisbourd C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-16 7,000 $1.93 7,000 No 4 M Direct
Common Stock Disposition 2021-07-16 7,000 $16.80 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-07-16 7,000 $0.00 7,000 $1.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,203 2028-11-09 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $16.32 to $17.365. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.